While all of us are focused on Acadia's results next week and the Angelman trial results hopefully within the next fortnight, I'm hoping that our intrepid CEO will be also giving us the results of the (few) pre-clinical mouse trials in the immediate future.
Not the time to be shorting the stock I would have thought.
While all of us are focused on Acadia's results next week and...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
-0.310(1.54%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.45 | $19.74 | $4.663M | 234.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | $19.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.89 | 765 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |